Clinical Trial: Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07626411) titled 'Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation' on May 29.

Brief Summary: This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly.

The aim of the study is to see how safe and effective REGN7508 is in preventing stroke and/or systemic embolism in participants with atrial fibrillation and how it compares against participants that will receive apixaban in this study.

The study is looking at ...